Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Mar 28, 2014 |
print number 209a |
Mar 28, 2014 |
amend and recommit to insurance |
Jan 08, 2014 |
referred to insurance |
Jan 09, 2013 |
referred to insurance |
Senate Bill S209A
2013-2014 Legislative Session
Sponsored By
(D, WF) Senate District
Archive: Last Bill Status - In Senate Committee Insurance Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Bill Amendments
2013-S209 - Details
- See Assembly Version of this Bill:
- A4372
- Current Committee:
- Senate Insurance
- Law Section:
- Insurance Law
- Laws Affected:
- Amd §§3216, 3221 & 4303, Ins L
- Versions Introduced in Other Legislative Sessions:
-
2009-2010:
S7977, A1134
2011-2012: S2880, A264
2015-2016: A299
2017-2018: A2667
2019-2020: A2846
2021-2022: A2272
2023-2024: A1792
2025-2026: A2476
2013-S209 - Summary
Provides that every policy which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or diagnostic X-rays shall provide coverage for testing of familial dysautonomia, Canavan's disease and Tay-Sachs; provides that in order to maintain the confidentiality of persons tested, receipt of acknowledgement from the testing facility shall be deemed sufficient evidence of testing.
2013-S209 - Sponsor Memo
BILL NUMBER:S209 TITLE OF BILL: An act to amend the insurance law, in relation to reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs PURPOSE OR GENERAL IDEA OF BILL: To authorize reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs SUMMARY OF PROVISIONS: Amends subsection (1) of Section 3216, subsection (1) of Section 3221 and Section 4303 of the Insurance Law, to authorize reimbursement for Familial Dysautonomia, Canavan's disease and Tay-Sachs testing. The bill also states that in order to maintain the confidentiality of persons tested, receipt of acknowledgment from the testing facility shall be deemed sufficient evidence of testing. JUSTIFICATION: Familial Dysautonomia, Canavan's disease and Tay-Sachs are genetic diseases which cause degeneration of the nervous system, and result in death. No treatment is currently available for any of these diseases, however, an infant can only be afflicted with the disease if both the mother and father are carriers. There is currently a
2013-S209 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 209 2013-2014 Regular Sessions I N S E N A T E (PREFILED) January 9, 2013 ___________ Introduced by Sen. SQUADRON -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance AN ACT to amend the insurance law, in relation to reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 30 to read as follows: (30) (A) EVERY POLICY WHICH PROVIDES COVERAGE FOR HOSPITAL, SURGICAL OR MEDICAL CARE OR PROVIDES REIMBURSEMENT FOR LABORATORY TESTS OR REIMBURSEMENT FOR DIAGNOSTIC X-RAY SERVICES SHALL PROVIDE COVERAGE FOR TESTING FOR FAMILIAL DYSAUTONOMIA, CANAVAN'S DISEASE AND TAY-SACHS. (B) SUCH COVERAGE SHALL BE INCLUDED AT THE INCEPTION OF ALL NEW POLI- CIES AND, WITH RESPECT TO ALL OTHER POLICIES, AT ANY ANNIVERSARY DATE OF THE POLICY SUBJECT TO EVIDENCE OF INSURABILITY. (C) FOR PURPOSES OF THIS PARAGRAPH, IN ORDER TO MAINTAIN THE CONFIDEN- TIALITY OF PERSONS TESTED, RECEIPT OF AN ACKNOWLEDGMENT FROM THE LABORA- TORY PERFORMING THE TEST FOR FAMILIAL DYSAUTONOMIA, CANAVAN'S DISEASE AND TAY-SACHS SHALL BE DEEMED SUFFICIENT EVIDENCE OF THE PERFORMANCE OF SUCH TESTING. (D) SUCH COVERAGE MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND CO-INSU- RANCE AS MAY BE DEEMED APPROPRIATE BY THE SUPERINTENDENT AND AS ARE CONSISTENT WITH THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A GIVEN POLICY. S 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 19 to read as follows: (19) (A) A GROUP POLICY WHICH PROVIDES COVERAGE FOR HOSPITAL, SURGICAL OR MEDICAL CARE OR PROVIDES REIMBURSEMENT FOR LABORATORY TESTS OR REIMBURSEMENT FOR DIAGNOSTIC X-RAY SERVICES SHALL PROVIDE COVERAGE FOR TESTING FOR FAMILIAL DYSAUTONOMIA, CANAVAN'S DISEASE AND TAY-SACHS. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
2013-S209A (ACTIVE) - Details
- See Assembly Version of this Bill:
- A4372
- Current Committee:
- Senate Insurance
- Law Section:
- Insurance Law
- Laws Affected:
- Amd §§3216, 3221 & 4303, Ins L
- Versions Introduced in Other Legislative Sessions:
-
2009-2010:
S7977, A1134
2011-2012: S2880, A264
2015-2016: A299
2017-2018: A2667
2019-2020: A2846
2021-2022: A2272
2023-2024: A1792
2025-2026: A2476
2013-S209A (ACTIVE) - Summary
Provides that every policy which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or diagnostic X-rays shall provide coverage for testing of familial dysautonomia, Canavan's disease and Tay-Sachs; provides that in order to maintain the confidentiality of persons tested, receipt of acknowledgement from the testing facility shall be deemed sufficient evidence of testing.
2013-S209A (ACTIVE) - Sponsor Memo
BILL NUMBER:S209A TITLE OF BILL: An act to amend the insurance law, in relation to reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs PURPOSE OR GENERAL IDEA OF BILL: To authorize reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs SUMMARY OF PROVISIONS: Amends subsection (1) of Section 3216, subsection (1) of Section 3221 and Section 4303 of the Insurance Law, to authorize reimbursement for Familial Dysautonomia, Canavan's disease and Tay-Sachs testing. The bill also states that in order to maintain the confidentiality of persons tested, receipt of acknowledgment from the testing facility shall be deemed sufficient evidence of testing. JUSTIFICATION: Familial Dysautonomia, Canavan's disease and Tay-Sachs are genetic diseases which cause degeneration of the nervous system, and result in death. No treatment is currently available for any of these diseases, however, an infant can only be afflicted with the disease if both the mother and father are carriers. There is currently a testing system in place which screens individuals before marriage to determine if they are carriers. This legislation would insure that individuals are able to receive reimbursement for medical screening
2013-S209A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 209--A 2013-2014 Regular Sessions I N S E N A T E (PREFILED) January 9, 2013 ___________ Introduced by Sen. SQUADRON -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance -- recommitted to the Committee on Insurance in accordance with Senate Rule 6, sec. 8 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the insurance law, in relation to reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 30 to read as follows: (30) (A) EVERY POLICY WHICH PROVIDES COVERAGE FOR HOSPITAL, SURGICAL OR MEDICAL CARE OR PROVIDES REIMBURSEMENT FOR LABORATORY TESTS OR REIMBURSEMENT FOR DIAGNOSTIC X-RAY SERVICES SHALL PROVIDE COVERAGE FOR TESTING FOR FAMILIAL DYSAUTONOMIA, CANAVAN'S DISEASE AND TAY-SACHS. (B) SUCH COVERAGE SHALL BE INCLUDED AT THE INCEPTION OF ALL NEW POLI- CIES AND, WITH RESPECT TO ALL OTHER POLICIES, AT ANY ANNIVERSARY DATE OF THE POLICY SUBJECT TO EVIDENCE OF INSURABILITY. (C) FOR PURPOSES OF THIS PARAGRAPH, IN ORDER TO MAINTAIN THE CONFIDEN- TIALITY OF PERSONS TESTED, RECEIPT OF AN ACKNOWLEDGMENT FROM THE LABORA- TORY PERFORMING THE TEST FOR FAMILIAL DYSAUTONOMIA, CANAVAN'S DISEASE AND TAY-SACHS SHALL BE DEEMED SUFFICIENT EVIDENCE OF THE PERFORMANCE OF SUCH TESTING. (D) SUCH COVERAGE MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND CO-INSU- RANCE AS MAY BE DEEMED APPROPRIATE BY THE SUPERINTENDENT AND AS ARE CONSISTENT WITH THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A GIVEN POLICY. S 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 19 to read as follows: EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD00235-02-4
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.